Cardiovascular Risk Stratification of Patients Undergoing Hematopoietic Stem Cell Transplantation : The CARE-BMT Risk Score
BACKGROUND: Evidence guiding the pre-hematopoietic stem cell transplantation (HSCT) cardiovascular evaluation is limited. We sought to derive and validate a pre-HSCT score for the cardiovascular risk stratification of HSCT candidates.
METHODS AND RESULTS: We leveraged the CARE-BMT (Cardiovascular Registry in Bone Marrow Transplantation) study, a contemporary multicenter observational study of adult patients who underwent autologous or allogeneic HSCT between 2008 and 2019 (N=2435; mean age at transplant of 55 years; 4.9% Black). We identified the subset of variables most predictive of post-HSCT cardiovascular events, defined as a composite of cardiovascular death, myocardial infarction, heart failure, stroke, atrial fibrillation or flutter, and sustained ventricular tachycardia. We then developed a point-based risk score using the hazard ratios obtained from Cox proportional hazards modeling. The score was externally validated in a separate cohort of 919 HSCT recipients (mean age at transplant 54 years; 20.4% Black). The risk score included age, transplant type, race, coronary artery disease, heart failure, peripheral artery disease, creatinine, triglycerides, and prior anthracycline dose. Risk scores were grouped as low-, intermediate-, and high-risk, with the 5-year cumulative incidence of cardiovascular events being 4.0%, 10.3%, and 22.4%, respectively. The area under the receiver operating curves for predicting cardiovascular events at 100 days, 5 and 10 years post-HSCT were 0.65 (95% CI, 0.59-0.70), 0.73 (95% CI, 0.69-0.76), and 0.76 (95% CI, 0.69-0.81), respectively. The model performed equally well in autologous and allogeneic recipients, as well as in the validation cohort.
CONCLUSIONS: The CARE-BMT risk score is easy to calculate and could help guide referrals of high-risk HSCT recipients to cardiovascular specialists before transplant and guide long-term monitoring.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
|---|---|
| Enthalten in: |
Journal of the American Heart Association - 13(2024), 1 vom: 02. Jan., Seite e033599 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Vasbinder, Alexi [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Atrial fibrillation |
|---|
| Anmerkungen: |
Date Completed 04.01.2024 Date Revised 15.02.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1161/JAHA.123.033599 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM366488724 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM366488724 | ||
| 003 | DE-627 | ||
| 005 | 20240215232000.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240108s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1161/JAHA.123.033599 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1294.xml |
| 035 | |a (DE-627)NLM366488724 | ||
| 035 | |a (NLM)38158222 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Vasbinder, Alexi |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cardiovascular Risk Stratification of Patients Undergoing Hematopoietic Stem Cell Transplantation |b The CARE-BMT Risk Score |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.01.2024 | ||
| 500 | |a Date Revised 15.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a BACKGROUND: Evidence guiding the pre-hematopoietic stem cell transplantation (HSCT) cardiovascular evaluation is limited. We sought to derive and validate a pre-HSCT score for the cardiovascular risk stratification of HSCT candidates | ||
| 520 | |a METHODS AND RESULTS: We leveraged the CARE-BMT (Cardiovascular Registry in Bone Marrow Transplantation) study, a contemporary multicenter observational study of adult patients who underwent autologous or allogeneic HSCT between 2008 and 2019 (N=2435; mean age at transplant of 55 years; 4.9% Black). We identified the subset of variables most predictive of post-HSCT cardiovascular events, defined as a composite of cardiovascular death, myocardial infarction, heart failure, stroke, atrial fibrillation or flutter, and sustained ventricular tachycardia. We then developed a point-based risk score using the hazard ratios obtained from Cox proportional hazards modeling. The score was externally validated in a separate cohort of 919 HSCT recipients (mean age at transplant 54 years; 20.4% Black). The risk score included age, transplant type, race, coronary artery disease, heart failure, peripheral artery disease, creatinine, triglycerides, and prior anthracycline dose. Risk scores were grouped as low-, intermediate-, and high-risk, with the 5-year cumulative incidence of cardiovascular events being 4.0%, 10.3%, and 22.4%, respectively. The area under the receiver operating curves for predicting cardiovascular events at 100 days, 5 and 10 years post-HSCT were 0.65 (95% CI, 0.59-0.70), 0.73 (95% CI, 0.69-0.76), and 0.76 (95% CI, 0.69-0.81), respectively. The model performed equally well in autologous and allogeneic recipients, as well as in the validation cohort | ||
| 520 | |a CONCLUSIONS: The CARE-BMT risk score is easy to calculate and could help guide referrals of high-risk HSCT recipients to cardiovascular specialists before transplant and guide long-term monitoring | ||
| 650 | 4 | |a Observational Study | |
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a atrial fibrillation | |
| 650 | 4 | |a bone marrow transplant | |
| 650 | 4 | |a cardiovascular disease | |
| 650 | 4 | |a heart failure | |
| 650 | 4 | |a hematopoietic stem cell transplant | |
| 650 | 4 | |a random forest | |
| 650 | 4 | |a risk score | |
| 700 | 1 | |a Catalan, Tonimarie |e verfasserin |4 aut | |
| 700 | 1 | |a Anderson, Elizabeth |e verfasserin |4 aut | |
| 700 | 1 | |a Chu, Catherine |e verfasserin |4 aut | |
| 700 | 1 | |a Kotzin, Megan |e verfasserin |4 aut | |
| 700 | 1 | |a Murphy, Danielle |e verfasserin |4 aut | |
| 700 | 1 | |a Cheplowitz, Halle |e verfasserin |4 aut | |
| 700 | 1 | |a Diaz, Kristen Machado |e verfasserin |4 aut | |
| 700 | 1 | |a Bitterman, Brayden |e verfasserin |4 aut | |
| 700 | 1 | |a Pizzo, Ian |e verfasserin |4 aut | |
| 700 | 1 | |a Huang, Yiyuan |e verfasserin |4 aut | |
| 700 | 1 | |a Xie, Jeffrey |e verfasserin |4 aut | |
| 700 | 1 | |a Hoeger, Christopher W |e verfasserin |4 aut | |
| 700 | 1 | |a Kaakati, Rayan |e verfasserin |4 aut | |
| 700 | 1 | |a Berlin, Hanna P |e verfasserin |4 aut | |
| 700 | 1 | |a Shadid, Husam |e verfasserin |4 aut | |
| 700 | 1 | |a Perry, Daniel |e verfasserin |4 aut | |
| 700 | 1 | |a Pan, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Takiar, Radhika |e verfasserin |4 aut | |
| 700 | 1 | |a Padalia, Kishan |e verfasserin |4 aut | |
| 700 | 1 | |a Mills, Jamie |e verfasserin |4 aut | |
| 700 | 1 | |a Meloche, Chelsea |e verfasserin |4 aut | |
| 700 | 1 | |a Bardwell, Alina |e verfasserin |4 aut | |
| 700 | 1 | |a Rochlen, Matthew |e verfasserin |4 aut | |
| 700 | 1 | |a Blakely, Pennelope |e verfasserin |4 aut | |
| 700 | 1 | |a Leja, Monika |e verfasserin |4 aut | |
| 700 | 1 | |a Banerjee, Mousumi |e verfasserin |4 aut | |
| 700 | 1 | |a Riwes, Mary |e verfasserin |4 aut | |
| 700 | 1 | |a Magenau, John |e verfasserin |4 aut | |
| 700 | 1 | |a Anand, Sarah |e verfasserin |4 aut | |
| 700 | 1 | |a Ghosh, Monalisa |e verfasserin |4 aut | |
| 700 | 1 | |a Pawarode, Attaphol |e verfasserin |4 aut | |
| 700 | 1 | |a Yanik, Gregory |e verfasserin |4 aut | |
| 700 | 1 | |a Nathan, Sunita |e verfasserin |4 aut | |
| 700 | 1 | |a Maciejewski, John |e verfasserin |4 aut | |
| 700 | 1 | |a Okwuosa, Tochukwu |e verfasserin |4 aut | |
| 700 | 1 | |a Hayek, Salim S |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of the American Heart Association |d 2012 |g 13(2024), 1 vom: 02. Jan., Seite e033599 |w (DE-627)NLM222412712 |x 2047-9980 |7 nnns |
| 773 | 1 | 8 | |g volume:13 |g year:2024 |g number:1 |g day:02 |g month:01 |g pages:e033599 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1161/JAHA.123.033599 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 13 |j 2024 |e 1 |b 02 |c 01 |h e033599 | ||